Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Szelenyi; Istvan
Address:
Schwaig, DE
No. of patents:
26
Patents:




Patent Number Title Of Patent Date Issued
7579365 Indolyl-3-glyoxylic acid derivatives having antitumor action August 25, 2009
The invention relates to the use of N-substituted indole-3-glyoxylamides of the general formula I as antitumor agents ##STR00001## and to a pharmaceutical composition having antitumor action, characterized in that it contains at least one of the compounds of the general formula 1, if
7553858 Combination of flupirtine and tramadol June 30, 2009
The subject of the present invention is to provide a combination of two centrally acting analgesics, flupirtine and tramadol, or their respective pharmaceutically acceptable salts for the treament of pain.
7521438 Combination of loteprednol and .beta..sub.2-adrenoceptor agonists April 21, 2009
The invention relates to a novel combination of a soft steroid, in particular loteprednol, and at least one .beta..sub.2 adrenoceptor agonist for the simultaneous, sequential or separate treatment of allergies and/or airway disorders, medicaments comprising the combination, processes
6436924 Antihistamine leukotriene combinations August 20, 2002
The invention relates to a pharmaceutical composition for the treatment of allergic rhinitis, vasomotor rhinitis, and allergic conjunctivitis, which comprises (a) a nonsedating antihistamine or a pharmaceutically acceptable salt thereof, (b) a leukotriene D.sub.4 antagonist, or a 5-lipox
6251932 Immunophilin ligands June 26, 2001
The invention relates to an immunophilin ligand of Formula I and having antiasthmatic, antiallergic, antirheumatic, immunosuppressant, antipsoriatic and neuroprotectant properties, ##STR1##
6232327 Indolyl-3-glyoxylic acid derivatives having antitumor action May 15, 2001
The invention relates to the use of N-substituted indole-3-glyoxylamides of the general formula I as antitumor agents ##STR1##and to a pharmaceutical composition having antitumor action, characterized in that it contains at least one of the compounds of the general formula 1, if appr
5776932 1,3,5-tribsubstituted indazole derivatives, processes for preparing, and for pharmacological tre July 7, 1998
1,3,5-trisubstituted indazole derivatives of the formula ##STR1## wherein R1 is H, (b) a C.sub.1-6 straight or branched, substituted or unsubstituted alkyl residue, (c) a C.sub.3-7 cycloalkyl residue, (d) an unsustituted or substituted phenyl, naphthyl, anthranyl, or fluorenyl re
5521178 Combination medication containing flupirtin and morphine for the treatment of pain and the preve May 28, 1996
A combination medication containing flupirtin and morphine for the treatment of pain and the prevention of morphine dependence
5284861 Pharmaceutical composition comprising flupirtine and its use to combat Parkinson disorders February 8, 1994
Flupirtine is used for the treatment of disorders involving skeletal muscle tension.
5162346 Pharmaceutical composition comprising flupirtine and its use to combat muscular tension November 10, 1992
Flupirtine is used for the treatment of disorders involving skeletal muscle tension.
5110814 Azelastine and its salts used to combat psoriasis May 5, 1992
The use of azelastine or its therapeutically acceptable salts and the preparation of a pharmaceutical composition for the treatment of inflammatory disorders and psoriasis disorders.
5021431 Imidazolyl alkyl guanidine derivatives, processes for their preparation and pharmaceutical prepa June 4, 1991
New imidazolylalkyl-guanidine derivatives are described, which by virtue of their agonistic action on histamine-H.sub.2 receptors and in part also due to their additional H.sub.1 -antagonistic receptor activity can be used in the treatment of cardiac diseases, certain forms of hypertensi
4946836 Nitrogen-containing cyclo-aliphatic compounds having an amino radical and a pyridine radical August 7, 1990
Compounds of formula ##STR1## wherein the radicals R.sub.1 and R.sub.2 are the same or different and represent hydrogen, halogen atoms, a trifluoromethyl group, a cyano, a nitro group, an amino group, a mono-C.sub.1 -C.sub.6 -alkylamino group, a di-C.sub.1 -C.sub.6 -alkylamino gr
4923858 Substituted 3-(n-heterocyclic)-2,6-diaminopyridines and -n-oxides May 8, 1990
Compounds of the general formula: ##STR1## wherein the radicals R.sub.1 and R.sub.2 are the same or different and represent hydrogen or C.sub.1 -C.sub.6 -alkyl, the radicals R.sub.3 and R.sub.4 are the same or different and represent hydrogen, C.sub.1 -C.sub.6 -alkyl, hydroxy, C.
4866066 Thiomethylpyridine derivatives and their use for eliciting a bronchosecretolytic or mucolytic re September 12, 1989
Thiomethylpyridine derivatives having bronchosecretolytic and mucolytic activity according to the formula: ##STR1## wherein R is a group attached in the 2-, 3- or 4-position of the pyridine ring which corresponds to the following general formula:wherein Q is a substituted or unsubsti
4810715 Imidazoyl-substituted thiomethylpyridine derivatives, method of administration thereof and medic March 7, 1989
Thiomethylpyridine derivatives having bronchosecretolytic and mucolytic activity according to the formula: ##STR1## wherein R is a group attached in the 2-, 3- or 4-position of the pyridine ring which corresponds to the following general formula: wherein Q is a substituted or unsubst
4738960 1,3,4-Thiadiazole derivatives and pharmaceutical preparations useful as inhibitors for histamine April 19, 1988
1,3,4-Thiadiazole derivatives corresponding to the general formula I ##STR1## which constitute highly effective inhibitors for histamine-H.sub.2 receptors are described. These compounds in addition have a cytoprotective action.
4732986 Benzothiazole derivatives, processes for their preparation and pharmaceutical compositions conta March 22, 1988
Benzothiazole derivatives corresponding to the general formula I ##STR1## wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4 represent, independently of one another, a hydrogen atom, a halogen atom, a linear C.sub.1 -C.sub.3 -alkyl group or a linear C.sub.1 -C.sub.3 -alkoxy group, R.sup.5
4727081 3,4-Diazole derivatives and pharmaceutical preparations containing these compounds February 23, 1988
3,4-Diazole derivatives corresponding to the general formula I ##STR1## which exert a highly selective action on histamine-H.sub.2 receptors are described. Processes for the preparation of these compounds and pharmaceutical preparations containing these compounds are also described.
4666921 Pyrazole derivatives, processes for their preparation and pharmaceutical preparations containing May 19, 1987
Special pyrazole derivatives corresponding to the general formula I which have a highly selective action on histamine-H.sub.2 receptors are described. Compared with other drugs known to be effective in their action on histamine-H.sub.2 receptors, these compounds have improved pharmac
4659721 Alkanol derivatives, and pharmaceutical preparation containing these compounds April 21, 1987
Alkanol derivatives corresponding to the general formula Iwhich have a highly selective action on histamine-H.sub.2 receptors are described. Due to this action, these compounds may advantageously be used for treatment of diseases caused by raised gastric secretion.
4656180 Diamine derivatives and pharmaceutical preparations containing these compounds April 7, 1987
Diamine derivatives corresponding to the general formula Iwhich have a highly selective action on histamine-H.sub.2 receptors and are therefore suitable for use as anti-ulcerative agents are described. Processes for the preparation of these compounds and pharmaceutical preparations conta
4600721 Pharmaceutical preparation July 15, 1986
Pharmaceutical preparations having an antiphlogistic action are described. The preparations contain, as active ingredient, a benzazole derivative corresponding to the general tautomeric formulae I ##STR1## wherein X represents a sulphur or oxygen atom and R.sup.1 represents a hyd
4599346 Propan-2-ol derivatives, a process for their production and medicaments containing these compoun July 8, 1986
The invention relates to new propan-2-ol derivatives corresponding to the following general formula ##STR1## in which R represents ##STR2## and to salts thereof with pharmacologically acceptable acids. These compounds have a selective effect on histamine-H.sub.2 -receptors.
4596811 Heterocyclic compounds, a process for their production and medicaments containing these compound June 24, 1986
The invention relates to special heterocyclic compounds corresponding to general tautomeric formula I which are distinguished by improved antagonistic activity on histamine-H.sub.2 -receptors. The invention also relates to a process for producing these compounds and to medicaments co
4559344 Pyridine-pyrimidinone derivatives, a process for their production and H.sub. -antagonist medicam December 17, 1985
The invention relates to new pyridine-pyrimidinone derivatives corresponding to the following general formula ##STR1## wherein R.sup.1 represents linear C.sub.1-6 alkyl or cycloalkyl and R.sup.2 represents linear C.sub.1-6 alkyl or R.sup.1 and R.sup.2 together with the nitrogen a


 
 
  Recently Added Patents
Packaging for a fiber-coupled optical device
Magazine for printing and converting heads, particularly for printing machines
Portable game hoist and skinning device
Method for validating the broadcasting conditions of content from a third party
Process and apparatus for thinning a semiconductor workpiece
Magnetic means for detachably and rotatably connecting components in an audio speaker system
Electronic apparatus
  Randomly Featured Patents
Heat sink clip assembly
Surface selection mechanism for optical storage system
Earphone
Bicycle ergometer body
Method and system for efficient maintenance of data coherency in a multiprocessor system utilizing cache synchronization
Edge tracing sewing machine capable of automatically adjusting needle position
Film cassette
Oscillatory mirror device with two exciting means
All wheel drive power buggy
Electric Actuator